The 2010 Government Supported Benefits 'Virtual' Summit
A unique web-based conference and series of accredited on-line self-learning programs focused on the impact of Heathcare reform on providers and patient care.
|
The 2010 Government Supported Benefits 'Virtual' Summit |
A unique web-based conference and series of accredited on-line self-learning programs focused on the impact of Heathcare reform on providers and patient care. |
|
Impact of Reimbursement Strategies for COPD Among Adults with Medicare Coverage
Needs Assessment
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD adversely affects patients’ quality of life and COPD sufferers consume a large amount of financial and patient care resources. Medicare beneficiaries with COPD may dwell in the community or long-term care facilities. Beneficiaries with COPD are responsible for the second highest amount of annual inpatient days, and were near the top in the average number of prescriptions and total expenditures consumed during their last years of life. Treatment is often compounded by concomitant conditions such as asthma, Chronic Heart Failure, and diabetes. Despite various guidelines and available treatments (occupational, physical, and medicinal therapies), few studies have examined the comparative effectiveness of different treatments in this vulnerable population. Research among this population was previously limited to the Medicare Current Beneficiary Survey, (MCBS a 5% sample of Medicare beneficiaries), and health plan specific databases. Recognizing the impact of COPD and the need for better data, the Centers for Medicare & Medicaid Services (CMS), included COPD in their Chronic Condition Data Warehouse launched in 2005, with additional information now captured through Medicare Part-D (CMS’ prescription plan initiated in 2006). Relationships between therapeutic and other interventions will be reviewed and discussed in terms of implications for emergency department utilization, hospital admissions and readmissions, costs, and other outcomes.
Learning Objectives:
Following completion of this program, participants will be able to:
To understand the prevalence and economic impact of COPD among Medicare beneficiaries.
Be familiar with the different data sources applicable to study COPD among Medicare Beneficiaries. (CMS’ CCW, MCBS, Part-D, and other data sources)
To understand the guidelines and spectrum of available therapies for persons with COPD: occupational, physical, and medicinal therapies and their comparative effectiveness.
To participate in the debate of balancing access, cost and outcomes to improve patient care in persons with COPD.
Agenda
Disclosures and Introduction (2 minutes)
The prevalence and economic impact of COPD among Medicare beneficiaries (15 minutes)
The different data sources applicable to study COPD among Medicare Beneficiaries. (CMS’ CCW, MCBS, Part-D, and other data sources) (15 minutes)
Guidelines and spectrum of available therapies for persons with COPD: occupational, physical, and medicinal therapies and their comparative effectiveness. (10 minutes)
Balancing access, cost and outcomes to improve patient care in persons with COPD (15 minutes)
References, Summary and Conclusions (3 min)